Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling

摘要

Endometrial (EM) cancer is the most common gynecological cancer worldwide and the incidence rose in the past decades. Cancer staging is an important part for management and the International Federation of Gynaecology and Obstetrics (FIGO) staging of EM cancer was revised in 2009, in which stage II was defined as cervical stromal invasion only.